Respiratory Emergency Medicine Cardiology Strong — validated in >15,000 patients; endorsed by ESC PE guidelines
Pulmonary Embolism Severity Index (PESI)
Predicts 30-day mortality in acute PE to guide disposition (inpatient vs outpatient management). Validated in multiple large cohorts.
References
- Aujesky D, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041–1046.
- Konstantinides SV, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41(4):543–603.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Nitric Oxide (Inhaled — iNO) · Selective Pulmonary Vasodilator
- Selexipag · Pulmonary Arterial Hypertension
- Macitentan · Pulmonary Arterial Hypertension
- Sildenafil (Paediatric — PPHN / PAH) · PDE5 Inhibitor (Paediatric Pulmonary Hypertension)
- Sildenafil · PDE5 Inhibitor — Pulmonary Arterial Hypertension
- Bosentan · Endothelin Receptor Antagonist — Pulmonary Arterial Hypertension
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
- Community-Acquired Pneumonia (CURB-65) · BTS 2009 / NICE NG138
- Acute Pulmonary Embolism · BTS 2003 / ESC 2019
- Pleural Effusion Assessment · BTS 2010
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.